Short interest for Alexandria Real Estate gives investors a sense of the degree to which investors are betting on the decline of Alexandria Real Estate's stock. Short interest data is updated every two weeks.

Alexandria Real Estate Stock (NYSE:ARE), Short Interest Report

Alexandria Real Estate

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.

Reit's,Concept,Is,Shown,By,Businessman.

REIT

Real Estate

MRNA

PINE

REITs Q1 Earnings Begin On Solid Note

Long Ideas

News

Dividends

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a  high dividend payout. 

Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Real Estate Stocks With Over 3% Dividend Yields

homes shutter

Macro Economic Events

Mid Cap

Sector ETFs

Bonds

Small Cap

Treasuries

Econ #s

Economics

Federal Reserve

ETFs

ACRE

CMTG

NYMT

PEAK

iShares FTSE NAREIT Mortgage PLUS Capped Index Fund

XLRE

U.S. housing market faces pressure as mortgage rates rise to 6.87%, highest in 2 months. Inflation data and bond yields trigger market sell-off.

Sticky Inflation, Surging Treasury Yields Push Mortgage Rates To 2-Month Peak: Real Estate Stocks Tumble

Alexandria Real Estate Equities, Inc. Common Stock

Alexandria Real Estate Equities Inc

American Rebel Holdings, Inc. - Common Stock

American Rebel Holdings Inc

American Resources Corporation - Class A Common Stock

American Resources Corp

American Resources Corp Warrants (27/08/2024)

The Arena Group Holdings, Inc. Common Stock

The Arena Group Holdings Inc

Ares Management Corporation Class A Common Stock

Ares Management Corp

Artis Real Estate Investment Trust

ARETE INDUS INC by Arete Industries, Inc.

Arete Industries Inc

AREV LIFE SCIENCES GLOBAL by AREV LIFE SCIENCES GLOBAL CORP.

AREV Life Sciences Global Corp

Archer Exploration Corp Ordinary Shares

In the latest quarter, 5 analysts provided ratings for Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $138.4, with a high estimate of $140.00 and a low estimate of $132.00. Witnessing a positive shift, the current average has risen by 1.02% from the previous average price target of $137.00.
<img src="https://www.benzinga.com/files/images/story/2024/1714060884_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Alexandria Real Estate. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steve Sakwa</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$132.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Aaron Hecht</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Omotayo Okusanya</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$140.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Alexandria Real Estate. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Alexandria Real Estate compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Alexandria Real Estate's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Alexandria Real Estate's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ARE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Alexandria Real Estate analyst ratings.</a>
<h2>Get to Know Alexandria Real Estate Better</h2>
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
<h3>Understanding the Numbers: Alexandria Real Estate's Finances</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3 months period, Alexandria Real Estate showcased positive performance, achieving a revenue growth rate of 9.75% as of 31 March, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Real Estate sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 21.7%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 0.9%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Alexandria Real Estate's ROA stands out, surpassing industry averages. With an impressive ROA of 0.45%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.68.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Landscape: 5 Takes On Alexandria Real Estate

Evercore ISI Group analyst Steve Sakwa maintains Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) with a Outperform and lowers the price target from $137 to $132.

Evercore ISI Group Maintains Outperform on Alexandria Real Estate, Lowers Price Target to $132

Wedbush analyst Richard Anderson reiterates Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) with a Outperform and maintains $140 price target.

Reiteration

Wedbush Reiterates Outperform on Alexandria Real Estate, Maintains $140 Price Target

Given the recent talk about higher interest rates being a headwind for real estate investment trusts (REITs), investors might anticipate that first-quarter operating results could be lackluster or subpar.
However, many initial REIT earnings reports are much better than expected, with several REITs beating the analyst estimates on funds from operations (FFO) or adjusted funds from operations (AFFO). Occupancy levels are still high and full-year 2024 FFO guidance looks sound.&nbsp;
Take a look at three REITs that just declared earnings and are showing up the analyst consensus estimates.&nbsp;
Alexandria Real Estate Equities Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is a Pasadena, California-based REIT with a portfolio of 800 tenants devoted to life science, agtech and advanced technology companies in what its website calls "top innovation clusters." These areas include cities like Boston, New York City, Seattle and San Francisco. Mega campuses make up 75% of its annual rental revenue. Alexandria is a member of the S&amp;P 500.
Don't Miss:
<ul>
<li>Investing in real estate just got a whole lot simpler. This <a href="https://www.benzinga.com/go/bezos-landlord">Jeff Bezos-backed startup will allow you to become a landlord</a> in just 10 minutes, and you only need $100.</li>
</ul>
Of Alexandria's leases, 94% are triple-net and 96% contain annual rent escalations. The weighted average remaining term (WALT) of its top 20 tenants is 9.7 years and for all tenants, the WALT is 7.5 years&nbsp; The tenant quality is strictly higher-grade with many of its tenants publicly traded on Wall Street. Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) and Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) are two of its largest tenants. The total occupancy rate as of the first quarter of 2024 was 94.6%.
Alexandria has reported positive news this month.&nbsp; On April 1, it announced an early renewal with insitro on a six-year lease extension through Aug. 31, 2034, in the San Francisco area. Insitro is a machine learning-powered drug discovery and development company.
On April 2, Alexandria announced it's been named one of Newsweek magazine's most trustworthy companies in America for the second consecutive year. Alexandria is first among the three S&amp;P 500 REITs recognized in the real estate and housing category.
On April 22, Alexandria declared its first-quarter operating results. AFFO of $2.35 per share beat the consensus estimate of $2.33 per share and was better than AFFO of $2.19 per share in the first quarter of 2023. Revenue of $769.1 million bested the Street estimate of $762.903 million and was substantially improved from first-quarter 2023 revenue of $700.795 million.
Trending
<ul>
<li>Want to Create a Passive Income Stream? <a href="https://www.benzinga.com/go/grow-wealth-passively">These High-Yield Real Estate Notes Might Be Your Holy Grail</a></li>
</ul>
Alexandria gave investors a hint that its first-quarter earnings would be strong when it increased the dividend by 5% in early March to $1.27 per share or $5.02 per share annually. The dividend yield is presently 4.39%.
Equity LifeStyle Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) is a Chicago-based residential REIT that owns and operates manufactured home communities, RV resorts, marinas and campgrounds in North America. Equity LifeStyles owns 450 communities across 35 states and British Columbia. It was founded in 1992 and had its initial public offering (IPO) in 1993.
On April 22, Equity LifeStyle reported its first-quarter operating results. FFO of $0.78 per share was above estimates for $0.77 and topped first-quarter 2023 FFO of $0.74 per share. Revenue of $386.6 million missed the consensus estimate of $389.49 million but solidly trounced the $370 million revenue it reported in the first quarter of 2023.
The forward guidance announced simultaneously with the operating results was even more positive. Equity LifeStyle sees full-year FFO between $1.83-$1.93 per share, well above the consensus estimate of $1.74 per share.
With single-family homes so expensive, manufactured homes remain an alternative for people who would love to buy a home but have a limited budget or down payment funds.
Alpine Income Property Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINE#NYSE">PINE</a>) is a Daytona Beach, Florida-based retail REIT that owns and operates 138 high-quality net-leased properties of 3.8 million square feet across 35 states. Sixty-five percent of its tenants are investment-grade companies such as Lowe's Cos. Inc., Dollar Tree Inc., Walgreens, Walmart Inc., Advanced Auto Parts and Dick's Sporting Goods. As of March 30, Alpine Income Property Trust had an occupancy rate of 99%.
On April 18, Alpine Income reported its first-quarter 2024 operating results. FFO of $0.41 per share topped the Street's view of $0.38 per share and its first-quarter 2023 FFO of $0.36 per share. Revenue of $12.47 million was ahead of analysts' estimates of $11.66 million and was 116% above revenue of $11.17 million in the first quarter of 2023. Alpine Income Property Trust maintained its full-year 2024 AFFO guidance from $1.53-$1.58 per share, slightly above the consensus estimate of $1.54 per share.&nbsp;
On April 19, Jones Trading analyst Jason Weaver maintained Alpine Income Property Trust with a Buy but lowered the price target from $19 to $18. On the same day, Stifel analyst Nathan Jones maintained a Buy on Alpine Income Property Trust but lowered the price target from $19 to $18.75.
&nbsp;&nbsp;Read Next:
<ul>
<li>Want To Grow Your Wealth Passively? Unlock Real Wealth with <a href="https://www.benzinga.com/money/cityfunds-yield">Cityfunds&#8217; Exclusive 8% Yield Fund</a>.</li>
</ul>

WIIM

Alexandria Real Estate shares are trading higher after the company reported better-than-expected Q1 financial results.

Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) reported quarterly AFFO of $2.35 per share which beat the analyst consensus estimate of $2.33 by 0.86 percent. The company reported quarterly sales of $769.100 million which beat the analyst consensus estimate of $762.903 million by 0.81 percent. This is a 9.75 percent increase over sales of $700.795 million the same period last year.

Earnings

Alexandria Real Estate Q1 2024 AFFO $2.35 Beats $2.33 Estimate, Sales $769.100M Beat $762.903M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; MainStreet Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNSB#NASDAQ">MNSB</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $17.10 million.
&bull; Dynex Cap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DX#NYSE">DX</a>) is likely to report quarterly loss at $0.09 per share on revenue of $-570 thousand.
&bull; Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) is projected to report quarterly earnings at $0.98 per share on revenue of $743.48 million.
&bull; Verizon Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) is likely to report quarterly earnings at $1.12 per share on revenue of $33.24 billion.
&bull; HBT Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBT#NASDAQ">HBT</a>) is projected to report quarterly earnings at $0.55 per share on revenue of $56.63 million.
&bull; AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) is projected to report quarterly earnings at $0.70 per share on revenue of $351.67 million.
&bull; Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) is estimated to report quarterly earnings at $0.80 per share on revenue of $5.70 billion.
&bull; Sify Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $149.30 million.
&bull; Washington Trust Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WASH#NASDAQ">WASH</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $31.50 million.
&bull; Bank of Hawaii (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOH#NYSE">BOH</a>) is estimated to report quarterly earnings at $0.87 per share on revenue of $160.21 million.
&bull; Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) is estimated to report earnings for its first quarter.
&bull; Albertsons Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACI#NYSE">ACI</a>) is expected to report quarterly earnings at $0.52 per share on revenue of $18.47 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Globe Life (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GL#NYSE">GL</a>) is expected to report quarterly earnings at $2.79 per share on revenue of $1.42 billion.
&bull; NBT Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBTB#NASDAQ">NBTB</a>) is likely to report quarterly earnings at $0.68 per share on revenue of $135.32 million.
&bull; Simpson Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSD#NYSE">SSD</a>) is expected to report quarterly earnings at $1.92 per share on revenue of $549.85 million.
&bull; Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) is projected to report quarterly earnings at $1.12 per share on revenue of $546.38 million.
&bull; Hexcel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HXL#NYSE">HXL</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $473.78 million.
&bull; RLI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLI#NYSE">RLI</a>) is expected to report quarterly earnings at $1.60 per share on revenue of $367.78 million.
&bull; Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is likely to report quarterly earnings at $2.32 per share on revenue of $772.57 million.
&bull; Ameriprise Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) is expected to report quarterly earnings at $8.20 per share on revenue of $4.12 billion.
&bull; Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $5.35 billion.
&bull; SAP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) is expected to report quarterly earnings at $1.11 per share on revenue of $8.56 billion.
&bull; AGNC Investment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $473.78 million.
&bull; Servisfirst Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SFBS#NYSE">SFBS</a>) is expected to report quarterly earnings at $0.88 per share on revenue of $109.10 million.
&bull; HealthStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) is likely to report quarterly earnings at $0.11 per share on revenue of $72.02 million.
&bull; Lufax Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>) is estimated to report quarterly earnings at $0.12 per share on revenue of $1.02 billion.
&bull; Equity Lifestyle Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $387.14 million.
&bull; SmartFinancial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMBK#NYSE">SMBK</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $39.14 million.
&bull; Trustco Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRST#NASDAQ">TRST</a>) is expected to report quarterly earnings at $0.60 per share on revenue of $43.13 million.
&bull; Independent Bank Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBTX#NASDAQ">IBTX</a>) is expected to report quarterly earnings at $0.59 per share on revenue of $121.39 million.
&bull; Medpace Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDP#NASDAQ">MEDP</a>) is likely to report quarterly earnings at $2.46 per share on revenue of $512.58 million.
&bull; Cathay General (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CATY#NASDAQ">CATY</a>) is likely to report quarterly earnings at $0.98 per share on revenue of $187.46 million.
&bull; Cadence Design Sys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) is likely to report quarterly earnings at $1.13 per share on revenue of $1.00 billion.
&bull; Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) is estimated to report quarterly earnings at $1.06 per share on revenue of $1.22 billion.
&bull; Pinnacle Finl Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PNFP#NASDAQ">PNFP</a>) is likely to report quarterly earnings at $1.56 per share on revenue of $423.19 million.
&bull; Cadence Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CADE#NYSE">CADE</a>) is expected to report quarterly earnings at $0.55 per share on revenue of $427.01 million.
&bull; SPDR ICE Preferred Securities ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSK#NYSE">PSK</a>) is estimated to report quarterly earnings at $0.18 per share on revenue of $129.00 million.
&bull; Enterprise Finl Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EFSC#NASDAQ">EFSC</a>) is expected to report quarterly earnings at $1.11 per share on revenue of $157.33 million.
&bull; RBB Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBB#NASDAQ">RBB</a>) is likely to report quarterly earnings at $0.34 per share on revenue of $27.65 million.
&bull; Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $228.14 million.
&bull; First Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) is estimated to report quarterly earnings at $0.42 per share on revenue of $31.41 million.
&bull; Packaging Corp of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>) is likely to report quarterly earnings at $1.62 per share on revenue of $1.90 billion.
&bull; Nucor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>) is likely to report quarterly earnings at $3.85 per share on revenue of $8.51 billion.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AGNC

CADE

CALX

CATY

CDNS

EFSC

FRBA

HSTM

IBTX

KSPI

MEDP

MNSB

NBTB

PNFP

SFBS

SIFY

SMBK

TRST

WASH

ZION

Earnings Scheduled For April 22, 2024

CUBE

EQIX

GLPI

Hannon Armstrong Sustainable Infrastructure Capital

HASI

LAMR

REXR

SBAC

VICI

Shares of REITs are trading lower as Treasury yields rise following hotter-than-expected March inflation data.

Alexandria Real Estate Equities, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative life science mega campuses in AAA innovation cluster locations, today announced that insitro, a leading machine learning-powered drug discovery and development company, has executed an early renewal for a 6-year lease extension through August 31, 2034&nbsp;for 143,188 RSF at 279 East Grand Avenue on the Alexandria Center&#xAE; for Advanced Technologies – South San Francisco mega campus in the San Francisco Bay Area.&nbsp;In 2018, recognizing the potential of insitro's innovative platform that leverages artificial intelligence (AI), and specifically machine learning (ML),&nbsp;and data at scale to decode complex biology and discover new medicines in therapeutic areas such as metabolism, oncology and neuroscience, Alexandria executed its first lease with insitro for nearly 36,000 RSF of Labspace&#xAE; infrastructure at 279 East Grand Avenue. The significant early renewal of insitro's headquarters and R&amp;D site underscores the drug discovery and development company's long-term commitment to the Alexandria Center for Advanced Technologies – South San Francisco mega campus. It also highlights the need for laboratory space to generate the large datasets that power AI capabilities in the discovery and development of new medicines and affirms that Alexandria is strongly positioned to enable companies working in the growing area of AI-enhanced laboratory-based research and development.
AI/ML hold immense potential to make the discovery and development of new medicines faster and more efficient, ultimately reducing the time and cost involved in the overall R&amp;D process — including the discovery of new biology, the development of novel therapies and the design of clinical trials. AI's power is derived from the application of computational approaches to high-quality data at scale. The complexity and volume of data needed to train AI models involve highly integrated R&amp;D infrastructure and drive the need for specialized technical laboratory space in Alexandria's core life science markets. With its goal of bringing better medicines faster to the patients who can benefit most through ML and data at scale, insitro is creating computational models of disease from massive laboratory-generated datasets and aggregated human cohort data to discover new biomarkers and genetic drivers of disease that anchor an advancing pipeline of therapeutics&nbsp;in liver disease, cancer and ALS (amyotrophic lateral sclerosis).
Alexandria entered South San Francisco, the birthplace of biotechnology, in 1998, and today the submarket is home to the densest concentration of life science companies in the San Francisco Bay Area. Over the past 25 years, Alexandria has strategically assembled a well-located footprint in South San Francisco, consisting of nearly 3.4 million RSF in operation as of December 31, 2023. The Alexandria Center for Advanced Technologies – South San Francisco mega campus, which aggregates 1.0 million RSF of operating properties and future development opportunities as of December 31, 2023, is at the heart of the submarket and is positioned to foster the growth of disruptive companies, like insitro. As part of Alexandria's purposeful efforts to enable its tenants to recruit and retain the brightest talent to advance their mission-critical science, the company is envisioning an elevated and activated ecosystem through the seamless integration of collaborative amenities into this mega campus, including a high-tech conference center, an inviting café and lounge, experiential walking paths promoting health and wellness, and enhanced connectivity to adjacent transportation hubs.

Alexandria Real Estate Equities Announces Early Renewal With insitro For A 6-Year Lease Extension At The Alexandria Center For Advanced Technologies Mega Campus In South San Francisco

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) in the last three months.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Alexandria Real Estate, revealing an average target of $143.5, a high estimate of $154.00, and a low estimate of $140.00. Observing a downward trend, the current average is 1.03% lower than the prior average price target of $145.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1709823618_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of Alexandria Real Estate by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Richard Anderson</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Aaron Hecht</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Omotayo Okusanya</td>
<td>Deutsche Bank</td>
<td>Announces</td>
<td>Buy</td>
<td>$140.00</td>
<td>-</td>
</tr>
<tr>
<td>Vikram Malhotra</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$154.00</td>
<td>$145.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Alexandria Real Estate. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Alexandria Real Estate compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Alexandria Real Estate's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Alexandria Real Estate's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ARE/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Alexandria Real Estate analyst ratings.</a>
<h2>Discovering Alexandria Real Estate: A Closer Look</h2>
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
<h3>Alexandria Real Estate: A Financial Overview</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Revenue Growth: Alexandria Real Estate's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 15.81%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Real Estate sector.
Net Margin: Alexandria Real Estate's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -11.7% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Alexandria Real Estate's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of -0.5%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Alexandria Real Estate's ROA stands out, surpassing industry averages. With an impressive ROA of -0.25%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.63, Alexandria Real Estate adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 4 Analyst Projections For Alexandria Real Estate

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a <a href="https://www.benzinga.com/yield-investments"> high dividend payout. </a>
Benzinga readers can review the latest analyst takes on&nbsp;their favorite stocks&nbsp;by visiting our&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings&nbsp;</a>page. Traders can sort through Benzinga&#39;s extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie"> by analyst accuracy </a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.
<h3>Host Hotels &amp; Resorts, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hst#NYSE">HST</a>)</h3>
<ul>
<li>Dividend Yield: 3.80%</li>
<li>Stifel analyst Simon Yarmak maintained a Buy rating and raised the price target from $20 to $21 on Jan. 24, 2024. This analyst has an accuracy rate of 63%.</li>
<li>Oppenheimer analyst Tyler Batory maintained an Outperform rating and boosted the price target from $21 to $23 on Jan. 5, 2024. This analyst has an accuracy rate of 69%.</li>
<li>Recent News: On Feb. 21, Host Hotels &amp; Resorts posted better-than-expected quarterly sales.</li>
</ul>
<h3>Alexandria Real Estate Equities, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/are#NYSE">ARE</a>)</h3>
<ul>
<li>Dividend Yield: 4.03%</li>
<li>Deutsche Bank analyst Omotayo Okusanya initiated coverage on the stock with a Buy rating and a price target of $140 on Jan. 30, 2024. This analyst has an accuracy rate of 60%.</li>
<li>Evercore ISI Group analyst Steve Sakwa maintained an Outperform rating and cut the price target from $137 to $135 on Aug. 17, 2023. This analyst has an accuracy rate of 60%.</li>
<li>Recent News: Alexandria Real Estate Equities said it will release its first quarter 2024 operating and financial results on April 23, 2024.</li>
</ul>
<h3>Regency Centers Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/reg#NYSE">REG</a>)</h3>
<ul>
<li>Dividend Yield: 4.26%</li>
<li>Wells Fargo analyst Dori Kesten initiated coverage on the stock with an Overweight rating and a price target of $70 on Feb. 1, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Truist Securities analyst Ki Bin Kim maintained a Buy rating and raised the price target from $71 to $72 on Jan. 16, 2024. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On Feb. 8, Regency Centers posted upbeat fourth-quarter sales.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/24/03/37474323/stitch-fix-target-and-3-stocks-to-watch-heading-into-tuesday"> Stitch Fix, Target And 3 Stocks To Watch Heading Into Tuesday</a>
&nbsp;

Wall Street's Most Accurate Analysts Say Buy These 3 Real Estate Stocks With Over 3% Dividend Yields

<h3>Companies Reporting Before The Bell</h3>
&bull; NIO (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
&bull; Target (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) is estimated to report quarterly earnings at $2.22 per share on revenue of $29.33 billion.
&bull; 2seventy bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSVT#NASDAQ">TSVT</a>) is expected to report quarterly loss at $0.99 per share on revenue of $14.71 million.
&bull; CLPS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPS#NASDAQ">CLPS</a>) is expected to report earnings for its first quarter.
&bull; Seres Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRB#NASDAQ">MCRB</a>) is projected to report quarterly loss at $0.50 per share on revenue of $350 thousand.
&bull; Vivid Seats (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEAT#NASDAQ">SEAT</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $183.67 million.
&bull; Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) is projected to report quarterly loss at $1.39 per share on revenue of $2.55 million.
&bull; Consolidated Comms Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>) is likely to report quarterly loss at $0.36 per share on revenue of $276.94 million.
&bull; CECO Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) is likely to report quarterly earnings at $0.24 per share on revenue of $146.61 million.
&bull; 908 Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASS#NASDAQ">MASS</a>) is expected to report quarterly loss at $0.26 per share on revenue of $14.16 million.
&bull; Neuronetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STIM#NASDAQ">STIM</a>) is projected to report quarterly loss at $0.26 per share on revenue of $19.85 million.
&bull; Broadwind (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWEN#NASDAQ">BWEN</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $50.15 million.
&bull; Global Business Travel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBTG#NYSE">GBTG</a>) is projected to report quarterly loss at $0.03 per share on revenue of $541.17 million.
&bull; Riskified (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSKD#NYSE">RSKD</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $84.02 million.
&bull; Angel Oak Mortgage REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>) is expected to report quarterly earnings at $0.18 per share on revenue of $9.00 million.
&bull; L.B. Foster (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSTR#NASDAQ">FSTR</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $129.35 million.
&bull; Rand Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAND#NASDAQ">RAND</a>) is expected to report earnings for its fourth quarter.
&bull; Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) is likely to report earnings for its fourth quarter.
&bull; Sophia Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOPH#NASDAQ">SOPH</a>) is projected to report quarterly loss at $0.26 per share on revenue of $17.33 million.
&bull; First Watch Restaurant Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRG#NASDAQ">FWRG</a>) is expected to report quarterly earnings at $0.04 per share on revenue of $237.53 million.
&bull; Compugen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEN#NASDAQ">CGEN</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $20.00 million.
&bull; SmartRent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMRT#NYSE">SMRT</a>) is likely to report quarterly loss at $0.01 per share on revenue of $59.49 million.
&bull; Ferguson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FERG#NYSE">FERG</a>) is estimated to report quarterly earnings at $1.85 per share on revenue of $6.77 billion.
&bull; Cipher Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) is estimated to report quarterly loss at $0.04 per share on revenue of $41.78 million.
&bull; Axogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXGN#NASDAQ">AXGN</a>) is likely to report quarterly loss at $0.10 per share on revenue of $41.65 million.
&bull; V2X (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $1.01 billion.
&bull; Wag Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PET#NASDAQ">PET</a>) is likely to report earnings for its fourth quarter.
&bull; Myers Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MYE#NYSE">MYE</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $196.19 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) is estimated to report quarterly earnings at $0.80 per share on revenue of $197.70 million.
&bull; Nordstrom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JWN#NYSE">JWN</a>) is estimated to report quarterly earnings at $0.88 per share on revenue of $4.39 billion.
&bull; BlackRock Cap Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKCC#NASDAQ">BKCC</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $20.32 million.
&bull; Presto Automation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRST#NASDAQ">PRST</a>) is likely to report earnings for its fourth quarter.
&bull; Kingsway Financial Servs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFS#NYSE">KFS</a>) is likely to report earnings for its fourth quarter.
&bull; Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) is expected to report quarterly loss at $0.19 per share on revenue of $293.53 million.
&bull; Cumberland (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPIX#NASDAQ">CPIX</a>) is likely to report earnings for its fourth quarter.
&bull; TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) is likely to report quarterly loss at $0.08 per share on revenue of $1.00 million.
&bull; Entravision Comms (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVC#NYSE">EVC</a>) is projected to report quarterly earnings at $0.07 per share on revenue of $308.47 million.
&bull; Bionano Genomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNGO#NASDAQ">BNGO</a>) is projected to report quarterly loss at $0.87 per share on revenue of $10.58 million.
&bull; Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) is likely to report quarterly loss at $3.66 per share on revenue of $73.50 million.
&bull; Marinus Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNS#NASDAQ">MRNS</a>) is expected to report quarterly loss at $0.62 per share on revenue of $8.01 million.
&bull; Allient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNT#NASDAQ">ALNT</a>) is expected to report quarterly earnings at $0.32 per share on revenue of $132.56 million.
&bull; Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) is projected to report quarterly earnings at $0.54 per share on revenue of $329.20 million.
&bull; Greenlight Capital Re (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLRE#NASDAQ">GLRE</a>) is estimated to report earnings for its fourth quarter.
&bull; Rigel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIGL#NASDAQ">RIGL</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $34.10 million.
&bull; Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) is projected to report quarterly loss at $1.07 per share on revenue of $1.06 million.
&bull; Socket Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCKT#NASDAQ">SCKT</a>) is estimated to report quarterly loss at $0.06 per share on revenue of $4.91 million.
&bull; Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) is expected to report quarterly loss at $0.40 per share on revenue of $1.95 million.
&bull; Park-Ohio Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PKOH#NASDAQ">PKOH</a>) is likely to report quarterly earnings at $0.55 per share on revenue of $386.45 million.
&bull; W&amp;T Offshore (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTI#NYSE">WTI</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $138.42 million.
&bull; Cadre Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CDRE#NYSE">CDRE</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $121.79 million.
&bull; Semler Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMLR#NASDAQ">SMLR</a>) is expected to report quarterly earnings at $0.57 per share on revenue of $14.50 million.
&bull; Agiliti (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGTI#NYSE">AGTI</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $291.41 million.
&bull; Nuvei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVEI#NASDAQ">NVEI</a>) is projected to report quarterly earnings at $0.45 per share on revenue of $319.51 million.
&bull; Franco-Nevada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNV#NYSE">FNV</a>) is estimated to report quarterly earnings at $0.84 per share on revenue of $283.00 million.
&bull; Mayville Engineering (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEC#NYSE">MEC</a>) is projected to report quarterly earnings at $0.13 per share on revenue of $152.30 million.
&bull; Aquestive Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AQST#NASDAQ">AQST</a>) is likely to report quarterly loss at $0.08 per share on revenue of $11.63 million.
&bull; Orthofix Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OFIX#NASDAQ">OFIX</a>) is expected to report earnings for its fourth quarter.
&bull; MeridianLink (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLNK#NYSE">MLNK</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $74.86 million.
&bull; Ross Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) is likely to report earnings for its fourth quarter.
&bull; Cerus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERS#NASDAQ">CERS</a>) is expected to report quarterly loss at $0.02 per share on revenue of $49.27 million.
&bull; American Public Education (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APEI#NASDAQ">APEI</a>) is projected to report quarterly earnings at $0.14 per share on revenue of $150.47 million.
&bull; Cricut (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRCT#NASDAQ">CRCT</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $249.68 million.
&bull; Crexendo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $13.80 million.
&bull; Aeva Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NYSE">AEVA</a>) is likely to report quarterly loss at $0.15 per share on revenue of $1.57 million.
&bull; LSB Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) is estimated to report quarterly earnings at $0.04 per share on revenue of $127.21 million.
&bull; PlayAGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGS#NYSE">AGS</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $92.57 million.
&bull; Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) is likely to report quarterly loss at $0.14 per share on revenue of $63.13 million.
&bull; CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) is expected to report quarterly earnings at $0.82 per share on revenue of $839.04 million.
&bull; HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) is expected to report quarterly earnings at $0.01 per share on revenue of $149.29 million.
&bull; Banco BBVA Argentina (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAR#NYSE">BBAR</a>) is estimated to report earnings for its fourth quarter.
&bull; NeuroPace (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) is expected to report quarterly loss at $0.31 per share on revenue of $17.46 million.
&bull; Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) is projected to report earnings for its fourth quarter.
&bull; Ooma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) is likely to report quarterly earnings at $0.12 per share on revenue of $61.46 million.
&bull; ChargePoint Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) is likely to report quarterly loss at $0.13 per share on revenue of $119.59 million.
&bull; ODDITY Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) is expected to report earnings for its fourth quarter.
&bull; NewtekOne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEWT#NASDAQ">NEWT</a>) is projected to report quarterly earnings at $0.58 per share on revenue of $63.35 million.
&bull; Box (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $262.95 million.
&bull; Weyco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEYS#NASDAQ">WEYS</a>) is projected to report earnings for its fourth quarter.
&bull; Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is likely to report earnings for its fourth quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

AEVA

AGTI

ALNT

AOMR

APEI

AQST

AXGN

BASE

BBAR

BKCC

BNGO

BWEN

CDRE

CECO

CERS

CGEN

CHPT

CIFR

CLPS

CNSL

CPIX

CRCT

CRWD

CXDO

DAVE

FERG

FSTR

FWRG

GBTG

GLRE

ISPO

MASS

MCRB

MLNK

MRNS

NEWT

NPCE

NUWE

NVEI

NYXH

OFIX

OOMA

PKOH

PRST

PSTV

RAND

RIGL

ROST

RSKD

SCKT

SEAT

SMLR

SMRT

SOPH

STIM

TCON

TSVT

VTOL

WEYS

Earnings Scheduled For March 5, 2024

The U.S. housing market faces increased pressure as the average contract interest rate for 30-year fixed-rate mortgages rose by seven basis points to 6.87%, a peak not seen in <a href="https://www.benzinga.com/real-estate">the past two months.</a>
This rise in mortgage rates, as reported by the Mortgage Bankers Association (MBA) on Wednesday, is a direct consequence of a slew of robust economic data and stickier-than-expected inflation, which have pushed long-term benchmark Treasury yields higher.
Amid these rising rates, the mortgage sector has experienced a downturn in activity, indicating the rising cost of borrowing for prospective homeowners. This was evidenced by a 2.3% decrease in mortgage applications, a notable pullback from the 3.7% gain observed in the preceding week. 
Chart: Mortgage Rates Saw A New Uptick Last Week
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-1024x495.png" alt="" class="wp-image-215751" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14092951/image-25.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">January&#8217;s Inflation Surprised To The Upside, Yields Rise</h2>
In January, the U.S. annual inflation rate was 3.1%, slowing down from December&#8217;s 3.4% print but coming in above expectations of 2.9%. The monthly rise in the Consumer Price Index (CPI) basket was also higher than expected (0.3% vs. 0.2%).
Particularly alarming was the core inflation rate, excluding volatile energy and food prices, which held firm at 3.9% year-on-year in January, surpassing the anticipated 3.7%.
Read also: <a href="https://www.benzinga.com/markets/equities/24/02/37105400/magnificent-7-lose-more-than-250-billion-as-blazing-inflation-data-triggers-market-sell-off">Magnificent 7 Lose More Than $250 Billion As Blazing Inflation Data Triggers Market Sell-Off</a>
The bond market, which plays a critical role in setting mortgage rates, reacted sharply to the inflation data. The yields on 10-year and 30-year Treasuries climbed to 4.30% and 4.47%, respectively, on Tuesday, echoing levels last seen in early December 2023, reflecting growing investor apprehension towards a resumption of inflationary pressures. 
Chart: 30-Year Treasury Yields Nears 4.5%, The Highest Since Late November
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-1024x495.png" alt="" class="wp-image-215754" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093102/image-27.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h2 class="wp-block-heading">Traders Trim Rate Cut Bets, Mortgage-Related Stocks Sink</h2>
Market speculators have adjusted their expectations regarding Federal Reserve rate cuts, now anticipating less than a full percentage point of cumulative reductions by December 2024—a significant revision from the 175 basis points anticipated just a month earlier.
Following the inflation report and the bond market&#8217;s response, the real estate sector emerged as one of the most adversely affected, with the Real Estate Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>) experiencing a 1.8% decline on Tuesday, reaching monthly lows. 
Similarly, the mortgage industry, as tracked by the iShares Mortgage Real Estate ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REM#NYSE">REM</a>), plummeted by 3.9%, marking its lowest point since mid-November 2023.
Among the most impacted stocks were Claros Mortgage Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMTG#NYSE">CMTG</a>), which saw an over 8% drop, Ares Commercial Real Estate Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>), down by 7.8%, and New York Mortgage Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYMT#NYSE">NYMT</a>), which fell by 6.3%.
Chart: Mortgage Real Estate Stocks Have Retraced More Than Half Of The Oct-Dec Rally
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-1024x495.png" alt="" class="wp-image-215767" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-1024x495.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-300x145.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-768x372.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29-1536x743.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/02/14093519/image-29.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read now: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/02/37099227/economists-sound-alarm-on-inflations-stubborn-grip-no-chance-inflation-will-return-">Economists Sound Alarm On Inflation&#8217;s Stubborn Grip: &#8216;No Chance Inflation Will Return To 2%&#8217; Without New Rate Hikes</a>
Image created with photos from Shutterstock.

Shares of REITs are trading lower amid a rise in Treasury yields, which could drive a rotation out of income-paying stocks.

Exploring Alexandria Real Estate Equities, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>), you&#8217;ll find a standout in the life sciences real estate arena, boasting a solid 4.4% dividend yield that speaks volumes about its top-notch operations and strategic spot where real estate meets biotech innovation. At the heart of their investment approach is a commitment to crafting top-tier life science and tech hubs, echoing Bill Gates&#8217; vision for groundbreaking innovation, health progress, and eco-friendly advancements. This synergy positions Alexandria not just as an investment option but as a prime pick for those eyeing returns that are both sustainable and geared towards significant growth, especially in a sector that&#8217;s as specialized as it is on a swift upward trajectory.
<h2 class="wp-block-heading">Don't Miss:</h2>
<ul>
<li>Investing in real estate just got a whole lot simpler. This<a href="https://www.benzinga.com/money/dara-khosrowshahi-backed-startup-lets-you-become-a-landlord-with-100"> Dara Khosrowshahi-backed startup</a> will allow you to become a landlord in just 10 minutes, and you only need $100.</li>
<li>Commercial real estate has historically outperformed the stock market, but few investors have the capital or resources needed to invest in this asset class. A platform backed by industry giant Marcus &amp; Millichap is changing that,<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> allowing individuals to invest in commercial real estate with as little as $5,000.&nbsp;</a></li>
</ul>
Investing in Alexandria Real Estate Equities resonates with Gates&#8217; investment approach, known for its emphasis on breakthrough growth, significant contributions to human health, and a commitment to leveraging science for global betterment. Similar to Gates&#8217; strategic investments through the Bill &amp; Melinda Gates Foundation and his personal portfolio, which often focus on healthcare, education, and clean energy, Alexandria invests in premium locations for life sciences and tech firms, creating ecosystems that foster innovation and collaboration among tenants. This approach is not only growth-focused but also underpins a stable revenue base, reflecting Gates&#8217; affinity for investments that offer both growth potential and societal impact.
Alexandria&#8217;s operational success is grounded in its strategic asset management and targeted expansion in key innovation hubs, which are crucial for maintaining and potentially enhancing its dividend offerings. The REIT&#8217;s ability to sustain high occupancy rates and attract leading biotech and pharmaceutical companies, alongside research institutions, underscores its adaptability and visionary outlook—traits that mirror Gates&#8217; approach to solving complex global challenges through innovation. The geographical diversity and strategic placement of its properties in major life science clusters contribute to risk mitigation and operational resilience.
Diving into Alexandria Real Estate Equities, you&#8217;re looking at a portfolio that&#8217;s nothing short of impressive, packed with state-of-the-art labs, bustling science and tech hubs, and a genuine green streak that meets the ever-evolving demands of the life sciences sector head-on. This unwavering commitment not only underscores Alexandria&#8217;s solid financial health and savvy planning but also resonates deeply with the kind of forward-thinking investment Bill Gates champions—ones that propel scientific breakthroughs and long-term value. Their knack for strategic portfolio management stands at the heart of their ability to keep dividends strong and growing, a sign of their steady performance that investors have come to rely on. With a dividend announcement of $1.27 per share in the last quarter of 2023, bringing the year&#8217;s total payouts to $4.96, it&#8217;s clear they&#8217;re on a promising path.
Putting your money into Alexandria Real Estate Equities means you&#8217;re getting in on a real estate venture that&#8217;s all about innovation and making a difference, much like the ethos Bill Gates lives by. With a laser focus on vital life science facilities, collaborative spaces, and a varied property mix, Alexandria is perfectly poised to tap into the surging demand for spaces where health meets tech. This mix of growth potential and income, drawing from a playbook that mirrors Gates&#8217; vision of looking ahead and making an impact, makes Alexandria Real Estate Equities a standout option for anyone looking to beef up their portfolio with a real estate asset that&#8217;s not just resilient but also has its eyes on the future.
&nbsp;Read Next:
<ul>
<li>Commercial real estate has historically outperformed the stock market, but few investors have the capital or resources needed to invest in this asset class. A platform backed by industry giant Marcus &amp; Millichap is changing that,<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> allowing individuals to invest in commercial real estate with as little as $5,000.&nbsp;</a></li>
<li>Collecting passive income from real estate just got a whole lot simpler. A new<a href="https://www.benzinga.com/money/dara-khosrowshahi-backed-startup-lets-you-become-a-landlord-with-100"> real estate fund backed by Dara Khosrowshahi</a> gives you instant access to a diversified portfolio of rental properties, and you only need $100 to get started.</li>
</ul>
Image credit: Shutterstock

Invest Like Bill Gates With This REIT

Life Science – Shady Grove mega campus in the Rockville submarket. Last year, AstraZeneca executed a 13-year lease term for the entire 84,264 RSF Class A+ property, which runs through June 30, 2036. Since 2007, Alexandria has provided AstraZeneca with essential and integrated manufacturing, laboratory and adjacent nontechnical infrastructure that currently aggregates nearly 417,000 RSF on campuses across its Maryland, Greater Boston and New York City clusters.

Financing

Alexandria Real Estate Equities Announces AstraZeneca Invests $300M In Manufacturing Facility

Alexandria Real Estate's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) short percent of float has fallen 7.93% since its last report. The company recently reported that it has 4.40 million shares sold short, which is 3.02% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.19 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Alexandria Real Estate Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1707496211_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Alexandria Real Estate has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Alexandria Real Estate's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Alexandria Real Estate's peer group average for short interest as a percentage of float is 8.42%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Alexandria Real Estate?

The senior notes due 2036 were priced at&nbsp;99.787%&nbsp;of the principal amount with a yield to maturity of&nbsp;5.271%, and the senior notes due 2054 were priced at&nbsp;99.943%&nbsp;of the principal amount with a yield to maturity of&nbsp;5.627%. The notes will be unsecured obligations of the Company and fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P., an indirectly&nbsp;100%&nbsp;owned subsidiary of the Company. The closing of the sale of the notes is expected to occur on or about&nbsp;February 15, 2024, subject to customary closing conditions.

Alexandria Real Estate Equities Prices Public Offering Of $400M 5.250% Senior Notes Due 2036 And $600M 5.625% Senior Notes Due 2054

JMP Securities analyst Aaron Hecht reiterates Alexandria Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) with a Market Outperform and maintains $140 price target.

JMP Securities Reiterates Market Outperform on Alexandria Real Estate, Maintains $140 Price Target

Baron Real Estate Income Fund Q1 2024 Shareholder Letter

Alexandria Is A BUY And The VC Arm Only Makes It Sweeter

7 Stocks I'm Buying The First Week Of May

Real estate stocks finish in green as analysts turn positive, earnings surprise to upside

Stagflation Is Back

Every Dividend Stock On My Buy List For May

Real estate stocks outperform major market averages as rate hikes are ruled out, earnings continue to grow

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Alexandria Real Estate Stock (NYSE:ARE), Short Interest Report

People Also Watch